Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Etienne

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|February 24, 2001
Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell linesJ L Fischel, P Rostagno, P Formento, et al.
Biochemical Pharmacology|June 1, 1997
Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitorJ L Fischel, P Formento, M C Etienne, et al.
British Journal of Cancer|August 7, 2001
Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesisS Marchetti, M Chazal, A Dubreuil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulationJ L Fischel, M C Etienne, T Spector, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Pharmacological background of EGFR targetingL Castillo, M C Etienne-Grimaldi, J L Fischel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Relationship between fluorouracil systemic exposure and tumor response and patient survivalG Milano, M C Etienne, N Renée, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer modelA Bozec, A Sudaka, N Toussan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patientsS Chéradame, M C Etienne, P Formento, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysisM C Etienne, E Chatelut, X Pivot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfectaP Beuzeboc, J Y Pierga, D Stoppa-Lyonnet, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|February 24, 2001
Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell linesJ L Fischel, P Rostagno, P Formento, et al.
Biochemical Pharmacology|June 1, 1997
Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitorJ L Fischel, P Formento, M C Etienne, et al.
British Journal of Cancer|August 7, 2001
Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesisS Marchetti, M Chazal, A Dubreuil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulationJ L Fischel, M C Etienne, T Spector, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Pharmacological background of EGFR targetingL Castillo, M C Etienne-Grimaldi, J L Fischel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Relationship between fluorouracil systemic exposure and tumor response and patient survivalG Milano, M C Etienne, N Renée, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer modelA Bozec, A Sudaka, N Toussan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patientsS Chéradame, M C Etienne, P Formento, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysisM C Etienne, E Chatelut, X Pivot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfectaP Beuzeboc, J Y Pierga, D Stoppa-Lyonnet, et al.
Pageof 10